News

Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
WVE-006, the leading GalNAc-RNA editing oligonucleotide designed to correct AAT protein and address both lung and liver ...
Mr. Joel Hassman Samuels has accepted the role of Provost, and will begin on Aug. 11, 2025. After two years of Willy Prado ...
McDonald's India (West & South) has announced the return of culinary icon Sanjeev Kapoor for a new brand film, created by DDB ...
U.S. President Donald Trump is playing 18 holes on his new golf course in Scotland as pressure grows for him to address ...
Two weeks after spending the Fourth of July on a popular South Carolina lake, 12-year-old Jaysen Carr died from a ...
The FDA has cleared investigational new drug applications for ZW251 and RV‑01, advancing novel treatments for solid tumors in first-in-human trials.
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Atossa’s progress reflects the strong strategic momentum promised in the March 11, 2025 announcement of a metastatic focus; momentum that aligns well with FDA expectations and regulatory standards, ...
Bagsværd, Denmark, 29 July 2025 - Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds La ...
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer ...